Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients

Conclusion: The diagnostic performance of trained neuroradiologists using brain MRI in pharmacovigilance of natalizumab-treated MS patients is moderately good. Interrater agreement among trained readers is fair to moderate.

http://msj.sagepub.com/cgi/content/abstract/22/9/1174?rss=1

Source: Multiple Sclerosis - July 25, 2016 Category: Neurology Authors: Wattjes, M. P., Wijburg, M. T., Vennegoor, A., Witte, B. I., Roosendaal, S. D., Sanchez, E., Liu, Y., Martins Jarnalo, C. O., Richert, N. D., Uitdehaag, B. M., Barkhof, F., Killestein, J. Tags: July 2016 22 (8) Original Research Papers Source Type: research